Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell
Laurent Knerr(AstraZeneca (Sweden)), Shalini Andersson(AstraZeneca (Sweden)), Eric Valeur(AstraZeneca (Sweden)), Leonardo De Maria(Novozymes (Denmark)), Elaine Pirie(Ionis Pharmaceuticals (United States)), Michael E. Østergaard(Ionis Pharmaceuticals (United States)), Johan Broddefalk(AstraZeneca (Sweden)), Linda Sundström(AstraZeneca (Sweden)), Rasmus Jansson‐Löfmark(AstraZeneca (Sweden)), Carina Ämmälä(AstraZeneca (Sweden)), Johan Meuller(AstraZeneca (Sweden)), Wuxia Fu(Ionis Pharmaceuticals (United States)), Maria Ölwegård-Halvarsson(AstraZeneca (Sweden)), Ahlke Hayen(AstraZeneca (Sweden)), Patrik Andersson(Karolinska Institutet), Punit P. Seth(Ionis Pharmaceuticals (United States)), Mehran Nikan(Ionis Pharmaceuticals (United States)), Thazha P. Prakash(Ionis Pharmaceuticals (United States)), William J. Drury(Ionis Pharmaceuticals (United States)), Richard Lee(Ionis Pharmaceuticals (United States)), David Janzén(AstraZeneca (Sweden))
Cited by 72
Related Papers
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
|Nature|2005|656
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary<i>N</i>-acetyl galactosamine improves potency 10-fold in mice
|Nucleic Acids Research|2014|594
The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue
|Cell Reports|2017|290
Pyrene-functionalized oligonucleotides and locked nucleic acids (LNAs): Tools for fundamental research, diagnostics, and nanotechnology
|Chemical Society Reviews|2011|256